Enovis Shares Outstanding 2010-2024 | ENOV
Enovis shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Enovis Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 54 |
| 2022 | 54 |
| 2021 | 51 |
| 2020 | 46 |
| 2019 | 46 |
| 2018 | 40 |
| 2017 | 41 |
| 2016 | 41 |
| 2015 | 42 |
| 2014 | 41 |
| 2013 | 33 |
| 2012 | 30 |
| 2011 | 15 |
| 2010 | 15 |
| 2009 | 14 |
| Enovis Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-03-31 | 55 |
| 2023-12-31 | 54 |
| 2023-09-30 | 55 |
| 2023-06-30 | 55 |
| 2023-03-31 | 54 |
| 2022-12-31 | 54 |
| 2022-09-30 | 54 |
| 2022-06-30 | 55 |
| 2022-03-31 | 54 |
| 2021-12-31 | 51 |
| 2021-09-30 | 53 |
| 2021-06-30 | 51 |
| 2021-03-31 | 47 |
| 2020-12-31 | 46 |
| 2020-09-30 | 46 |
| 2020-06-30 | 46 |
| 2020-03-31 | 47 |
| 2019-12-31 | 46 |
| 2019-09-30 | 46 |
| 2019-06-30 | 46 |
| 2019-03-31 | 45 |
| 2018-12-31 | 40 |
| 2018-09-30 | 39 |
| 2018-06-30 | 41 |
| 2018-03-31 | 41 |
| 2017-12-31 | 41 |
| 2017-09-30 | 41 |
| 2017-06-30 | 41 |
| 2017-03-31 | 41 |
| 2016-12-31 | 41 |
| 2016-09-30 | 41 |
| 2016-06-30 | 41 |
| 2016-03-31 | 41 |
| 2015-12-31 | 42 |
| 2015-09-30 | 42 |
| 2015-06-30 | 42 |
| 2015-03-31 | 42 |
| 2014-12-31 | 41 |
| 2014-09-30 | 42 |
| 2014-06-30 | 42 |
| 2014-03-31 | 38 |
| 2013-12-31 | 33 |
| 2013-09-30 | 38 |
| 2013-06-30 | 37 |
| 2013-03-31 | 32 |
| 2012-12-31 | 30 |
| 2012-09-30 | 32 |
| 2012-06-30 | 32 |
| 2012-03-31 | 27 |
| 2011-12-31 | 15 |
| 2011-09-30 | 15 |
| 2011-06-30 | 15 |
| 2011-03-31 | 15 |
| 2010-12-31 | 15 |
| 2010-09-30 | 15 |
| 2010-06-30 | 15 |
| 2010-03-31 | 14 |
| 2009-12-31 | 14 |
| 2009-09-30 | 14 |
| 2009-06-30 | 14 |
| 2009-03-31 | 14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.806B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.316B | 20.49 |
| Inspire Medical Systems (INSP) | United States | $4.614B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.995B | 0.00 |
| Axonics (AXNX) | United States | $3.446B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.976B | 0.00 |
| 10x Genomics (TXG) | United States | $2.959B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.881B | 0.00 |
| Azenta (AZTA) | United States | $2.776B | 156.00 |
| Privia Health (PRVA) | United States | $1.920B | 107.27 |
| Schrodinger (SDGR) | United States | $1.643B | 0.00 |
| Omnicell (OMCL) | United States | $1.411B | 48.78 |
| Phreesia (PHR) | United States | $1.359B | 0.00 |
| Standard BioTools (LAB) | United States | $0.749B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.669B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Talkspace (TALK) | United States | $0.475B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.445B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.408B | 0.00 |
| Pulmonx (LUNG) | United States | $0.346B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.297B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.219B | 0.00 |
| Outset Medical (OM) | United States | $0.187B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.173B | 0.00 |
| American Well (AMWL) | United States | $0.151B | 0.00 |
| TruBridge (TBRG) | United States | $0.135B | 7.26 |
| 111 (YI) | China | $0.111B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.099B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.080B | 0.00 |
| HeartBeam (BEAT) | United States | $0.067B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.056B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Cue Health (HLTH) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |